V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159271 | 20061129 | 1.79 | 66.35 | Curative (C) | 2016-06-02 | 2016-06-22 | ECX | 02 | N | ECX | 101225062 |
| 20159274 | 20061130 | 1.69 | 64 | Curative (C) | 2016-09-05 | 2016-09-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101700273 |
| 20159275 | 20061131 | 1.73 | 75 | Adjuvant (A) | 2018-08-17 | 2018-09-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101612523 |
| 20159276 | 20061132 | 1.88 | 62.9 | Neo-adjuvant (N) | 2016-10-14 | 2016-10-24 | ECX | N | N | ECX | 100302755 |
| 20159278 | 20061133 | 1.72 | 93.25 | Palliative (P) | 2016-03-02 | 2016-03-06 | ECX | 02 | N | ECX | 100245328 |
| 20159280 | 20061134 | 1.63 | 70.3 | Curative (C) | 2019-07-13 | 2019-07-13 | ECX | 02 | N | ECX | 101029550 |
| 20159282 | 20061135 | 1.59 | 82.6 | Neo-adjuvant (N) | 2016-07-24 | 2016-07-28 | ECX | N | Y | ECX | 100546622 |
| 20159283 | 20061136 | 1.1 | 67 | Adjuvant (A) | 2017-12-14 | 2017-12-15 | ECX | 02 | N | ECX | 100044579 |
| 20159284 | 20061137 | null | 70.35 | Neo-adjuvant (N) | 2019-03-28 | 2019-03-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100296588 |
| 20159286 | 20061138 | 1.83 | 51.4 | Adjuvant (A) | 2019-04-18 | 2019-04-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101147578 |
| 20159287 | 20061139 | null | null | null | null | 2019-01-17 | ECX | N | N | ECX | 101861326 |
| 20159288 | 20061140 | 1.76 | 113 | Neo-adjuvant (N) | 2017-06-24 | 2017-08-21 | ECX | 02 | N | ECX | 100951154 |
| 20159289 | 20061141 | 1.78 | 56.45 | Palliative (P) | 2018-07-06 | 2018-08-21 | ECX | N | N | ECX | 101607755 |
| 20159290 | 20061142 | 1.73 | 79.6 | Adjuvant (A) | 2019-06-10 | 2019-06-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101697371 |
| 20159294 | 20061143 | 1.73 | 87.5 | Palliative (P) | 2019-03-11 | 2019-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101349051 |
| 20159297 | 20061144 | 1.61 | 73 | Adjuvant (A) | 2020-03-01 | 2020-03-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101782682 |
| 20159299 | 20061145 | 1.74 | 75.6 | Palliative (P) | 2018-05-07 | 2018-05-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101601677 |
| 20159300 | 20061146 | 1.64 | 83.5 | Neo-adjuvant (N) | 2016-03-03 | 2016-03-11 | ECX | 2 | N | ECX | 101131971 |
| 20159301 | 20061147 | 1.59 | 82.2 | Adjuvant (A) | 2018-06-24 | 2018-07-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100777640 |
| 20159303 | 20061148 | 1.55 | 85.8 | Neo-adjuvant (N) | 2019-09-26 | 2019-10-14 | ECX | 02 | N | ECX | 101058611 |
| 20159306 | 20061149 | 1.7 | 63.7 | Palliative (P) | 2017-10-27 | 2017-11-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100988146 |
| 20159310 | 20061150 | 1.65 | 63.7 | Palliative (P) | 2016-04-10 | 2016-04-28 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100339263 |
| 20159311 | 20061151 | 1.54 | 60 | Neo-adjuvant (N) | 2019-07-06 | 2019-07-13 | ECX | N | N | ECX | 101004403 |
| 20159312 | 20061152 | 1.88 | 74.6 | Curative (C) | 2016-12-07 | 2016-12-08 | ECX | N | N | ECX | 101653449 |
| 20159313 | 20061153 | 1.77 | 107.4 | Neo-adjuvant (N) | 2018-12-06 | 2018-12-08 | ECX | 02 | null | ECX | 101194160 |
| 20159315 | 20061154 | 1.6 | 63.8 | Adjuvant (A) | 2017-09-29 | 2017-10-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101800713 |
| 20159317 | 20061155 | 1.49 | 66.7 | Curative (C) | 2017-05-12 | 2017-05-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100107020 |
| 20159318 | 20061156 | 1.72 | 78.05 | Adjuvant (A) | 2016-04-30 | 2016-05-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101398261 |
| 20159322 | 20061157 | 1.74 | 71 | null | 2016-02-19 | 2016-02-26 | Gemcitabine + Capecitabine | N | N | ECX | 101508973 |
| 20159324 | 20061158 | 1.7 | 108 | Palliative (P) | 2018-03-03 | 2018-03-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101474322 |
| 20159327 | 20061159 | 1.78 | 86 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-14 | ECX | N | N | ECX | 101597226 |
| 20159330 | 20061160 | 1.57 | 111.4 | Adjuvant (A) | null | 2017-11-08 | CAPECITABINE + GEMCITABINE | 99 | N | CAPECITABINE + GEMCITABINE | 101073347 |
| 20159332 | 20061161 | 1.75 | 69.2 | Adjuvant (A) | 2016-11-24 | 2016-12-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101852263 |
| 20159335 | 20061162 | 1.56 | 55.45 | Adjuvant (A) | 2016-11-25 | 2016-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101272342 |
| 20159336 | 20061163 | 1.68 | 96 | Neo-adjuvant (N) | 2018-06-19 | 2018-06-29 | ECX | N | N | ECX | 100000942 |
| 20159338 | 20061164 | 1.51 | 45.85 | Adjuvant (A) | 2018-05-28 | 2018-06-15 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101012896 |
| 20159339 | 20061165 | 1.79 | 49 | Palliative (P) | 2017-12-01 | 2017-12-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101769583 |
| 20159340 | 20061166 | 1.58 | null | Neo-adjuvant (N) | 2016-05-19 | 2016-05-28 | ECX | N | N | ECX | 100964988 |
| 20159341 | 20061167 | 1.56 | 54.4 | Palliative (P) | 2017-07-27 | 2017-07-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100174610 |
| 20159343 | 20061168 | 1.8 | 73.2 | Adjuvant (A) | null | 2017-06-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100618274 |
| 20159344 | 20061169 | 1.53 | 90 | Neo-adjuvant (N) | 2019-01-28 | 2019-01-28 | ECX | 02 | N | ECX | 100532329 |
| 20159345 | 20061170 | 1.62 | 53.6 | Adjuvant (A) | 2017-12-17 | 2017-12-30 | ECX | 02 | N | ECX | 100456931 |
| 20159346 | 20061171 | 1.6 | 78.4 | Palliative (P) | 2019-08-27 | 2019-09-03 | ECX | N | N | ECX | 101514083 |
| 20159349 | 20061172 | 1.63 | 64 | Adjuvant (A) | 2019-01-31 | 2019-02-14 | ECX | N | N | ECX | 100842706 |
| 20159350 | 20061173 | 1.68 | 81.8 | Adjuvant (A) | 2018-10-24 | 2018-10-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100837963 |
| 20159351 | 20061174 | 1.7 | 82 | Palliative (P) | 2018-03-18 | 2018-03-31 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101040032 |
| 20159353 | 20061175 | 1.7 | 63.7 | Neo-adjuvant (N) | 2017-08-27 | 2017-09-22 | ECX | 02 | null | ECX | 101209711 |
| 20159355 | 20061176 | 1.71 | 64.4 | Adjuvant (A) | 2017-01-16 | 2017-01-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100800790 |
| 20159356 | 20061177 | 1.84 | 88.4 | Neo-adjuvant (N) | 2018-11-02 | 2018-11-05 | ECX | N | N | ECX | 100005760 |
| 20159357 | 20061178 | 1.54 | 117.8 | Palliative (P) | 2017-10-29 | 2017-11-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100377675 |